GENERAC HOLDINGS ($GNRC) posted quarterly earnings results on Wednesday, July 30th. The company reported earnings of $1.65 per share, beating estimates of $1.37 by $0.28. The company also reported revenue of $1,061,170,000, beating estimates of $1,046,287,389 by $14,882,611.
You can see Quiver Quantitative's $GNRC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GENERAC HOLDINGS Insider Trading Activity
GENERAC HOLDINGS insiders have traded $GNRC stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $GNRC stock by insiders over the last 6 months:
- AARON JAGDFELD (Chief Executive Officer) has made 0 purchases and 3 sales selling 15,000 shares for an estimated $2,075,100.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GENERAC HOLDINGS Hedge Fund Activity
We have seen 330 institutional investors add shares of GENERAC HOLDINGS stock to their portfolio, and 411 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,123,079 shares (-78.9%) from their portfolio in Q1 2025, for an estimated $142,237,955
- UBS GROUP AG removed 729,098 shares (-47.1%) from their portfolio in Q1 2025, for an estimated $92,340,261
- CAPITAL WORLD INVESTORS removed 576,796 shares (-43.3%) from their portfolio in Q1 2025, for an estimated $73,051,213
- MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 419,910 shares (-58.9%) from their portfolio in Q1 2025, for an estimated $53,181,601
- AMERIPRISE FINANCIAL INC removed 396,377 shares (-73.7%) from their portfolio in Q1 2025, for an estimated $50,201,147
- FOREST AVENUE CAPITAL MANAGEMENT LP removed 318,046 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $40,280,525
- INVESCO LTD. added 285,388 shares (+25.3%) to their portfolio in Q1 2025, for an estimated $36,144,390
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GENERAC HOLDINGS Congressional Stock Trading
Members of Congress have traded $GNRC stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $GNRC stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GENERAC HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $GNRC in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 07/29/2025
- UBS issued a "Buy" rating on 07/24/2025
- Stephens & Co. issued a "Overweight" rating on 05/27/2025
- Canaccord Genuity issued a "Buy" rating on 05/01/2025
- TD Securities issued a "Buy" rating on 05/01/2025
- Stifel issued a "Buy" rating on 05/01/2025
- Piper Sandler issued a "Overweight" rating on 04/17/2025
To track analyst ratings and price targets for GENERAC HOLDINGS, check out Quiver Quantitative's $GNRC forecast page.
GENERAC HOLDINGS Price Targets
Multiple analysts have issued price targets for $GNRC recently. We have seen 15 analysts offer price targets for $GNRC in the last 6 months, with a median target of $168.0.
Here are some recent targets:
- Joseph Osha from Guggenheim set a target price of $190.0 on 07/29/2025
- Jon Windham from UBS set a target price of $200.0 on 07/24/2025
- Chip Moore from Roth Capital set a target price of $140.0 on 07/22/2025
- Mark Strouse from JP Morgan set a target price of $144.0 on 07/22/2025
- Christine Cho from Barclays set a target price of $170.0 on 07/18/2025
- Tommy Moll from Stephens & Co. set a target price of $175.0 on 05/27/2025
- George Gianarikas from Canaccord Genuity set a target price of $180.0 on 05/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
